Fulvestrant and malignant neoplasm progression Patient Reports February 12, 2012

Fulvestrant Side Effects Report #4595987-0
Fulvestrant side effect was reported by a Physician from on Feb 09, 2005. Female patient, 64 years of age, weighting 145.5 lb, was diagnosed with breast cancer metastatic and was treated with Fulvestrant. After drug was administered, patient experienced the following side effects: anorexia, asthenia, cryptogenic organizing pneumonia, diarrhoea, dizziness postural, headache , malignant neoplasm progression, pulmonary embolism , pyrexia. Fulvestrant dosage: 250 MG Q4WK IM. During the same period patient was treated with BUDESONIDE, CETRIZINE, DOCLORAZE, SELENIUM TRACE METAL ADDITIVE, CITALOPRAM HYDROBROMIDE, IMODIUM, PULMICORT. Patient was hospitalized. Patient recovered.

Fulvestrant Side Effects Report #4621093-2
Fulvestrant side effect was reported by a Physician from on Mar 15, 2005. Female patient, 64 years of age, weighting 145.5 lb, was diagnosed with breast cancer metastatic and was treated with Fulvestrant. After drug was administered, patient experienced the following side effects: anorexia, breast cancer metastatic, cryptogenic organizing pneumonia, diarrhoea, dizziness postural, headache , malignant neoplasm progression, metastases to lung, pulmonary embolism . Fulvestrant dosage: 250 MG Q4WK IM. During the same period patient was treated with BUDESONIDE, CETRIZINE, DOCLORAZE, SELENIUM TRACE METAL ADDITIVE, CITALOPRAM, IMODIUM, PULMICORT. Patient was hospitalized. Patient recovered.